An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM)J Clin Oncol - Moulton, C; Levine, M N; Law, C (2011)
et al.